Table 2. Case Series of 15 Mohs Wounds With Initial Wound Management With EZ-DERM™

 

Pt

Age

(years)

Sex

Tumor

Location

Final Wound

Size (cm)

Mohs Stages/Blocks

Or Staged Excisions

Wound Features

Subsequent

Wound

Management

Wound

Complication

1

81

M

pBCC

Upper Chest

8.9 x 4.7

II (10)

~

SIH

~

2

81

M

pLM

Nose

3.9 x 2.9

2

TMD

F

~

3

89

W

pBCC

Scalp

6.0 x 5.7

II (9)

BO

SIH

~

4

88

M

pMAC

Cheek, Nose

& Lip

7.2 x 5.0

VII (28)

~

SIH

Ectropion

Eclabion

5

85

M

pBCC

Nose

3.7 x 3.0

III (11)

~

FTSG

~

6

79

M

pBCC

Nose

2.9 x 2.2

VII (9)

C

SIH

~

7

83

W

rBCC

Nose

2.3 x 2.0

II (3)

C

FTSG

MRSA

8

80

W

pmBCC

Nose

2.6 x 1.6

V (7)

TMD, C

F

~

9

49

M

pmBCC

Nose

3.4 x 2.8

V (9)

~

F

~

10

63

M

pLM

Scalp

3.5 x 3.0

1

~

F

~

11

77

W

rBCC

Nose

3.7 x 2.9

VIII (9)

~

F

~

12

72

W

rBCC

Nose

1.8 x 1.8

II (6)

TMD

ACG, FTSG

~

13

63

M

pBCC

Nose

3.2 x 2.2

II (5)

B

SIH, F

~

14

49

W

psBCC

Nose

1.2 x 0.9

II (3)

~

ACG, FTSG

~

15

84

W

rBCC

Nose

2.8 x 2.0

III (5)

TMD, C

F

~

 

Pt = Patient; M = Man; W = Woman; ACG = Auricular Cartilage Graft; B =Bone Exposed with intact Periosteum; BO = Bone exposure without Periosteum; C = Cartilage exposed; F = Flap; FTSG = Full Thickness Skin Graft; MRSA = Methicillin-resistant Staphylococcus aureus; pBCC = Primary Basal Cell Carcinoma, pLM = Primary Lentigo Maligna; pMAC = Primary Microcystic Adnexal Carcinoma; pmBCC = Primary Micronodular Basal Cell Carcinoma; rBCC = Recurrent Basal Cell Carcinoma; SIH = Second Intention Healing; TMD = Through and Through Mucosal Defect